XML 51 R39.htm IDEA: XBRL DOCUMENT v3.25.3
Schedule of Stock Option Activities (Details) - USD ($)
 9 Months Ended 12 Months Ended
Sep. 30, 2025
Sep. 30, 2024
Dec. 31, 2024
Share-Based Payment Arrangement [Abstract]      
Outstanding, shares 5,788,597    
Weighted average exercise price, per share $ 2.97    
Outstanding, weighted-average remaining contractual term (Year) 4 years 6 months 14 days   5 years 4 months 2 days
Outstanding, aggregate intrinsic value $ 655,578    
Shares granted [1] 698,500    
Granted, weighted average exercise price [1] $ 1.71    
Shares canceled (55,000) [2] (5,569)  
Exercised, weighted average exercise price [2] $ 1.17    
Shares canceled [3] (500,000)    
Canceled, weighted average exercise price [3] $ 2.95    
Outstanding, shares 5,932,097   5,788,597
Weighted average exercise price, per share $ 2.84   $ 2.97
Outstanding, aggregate intrinsic value $ 3,575   $ 655,578
Exercisable, shares 4,718,372    
Exercisable, weighted average exercise price $ 3.10 $ 1.63  
Exercisable, weighted-average remaining contractual term (Year) 3 years 7 months 9 days    
Exercisable, aggregate intrinsic value    
[1] Annual share-based compensation awards on January 2, 2025, with an exercise price of $1.74, including: (a) 356,500 stock options granted to executives and key personnel, vesting upon one year anniversary, or annually in equal installments over four years, (b) 277,500 stock options granted to members of the Board of Directors, vesting upon one year anniversary, (c) 19,500 stock options granted to employees, vesting annually in equal installments over four years, and (d) 20,000 stock options granted to a consultant, vesting upon one year anniversary.
[2] Represents the following options exercised:
[3] Represents the following options canceled: